Corvus Pharmaceuticals, Inc. Temporary Equity, Liquidation Preference
Corvus Pharmaceuticals, Inc. (CRVS) had Temporary Equity, Liquidation Preference of $0 as of 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2017-03-10
- 2016-09-30: Temporary Equity, Liquidation Preference $0.00.
- 2016-06-30: Temporary Equity, Liquidation Preference $0.00.
- 2016-03-31: Temporary Equity, Liquidation Preference $0.00.
- 2015-12-31: Temporary Equity, Liquidation Preference $108.50M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $108.50M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |